Literature DB >> 16879259

Epitopes of the class I major histocompatibility complex (MHC-I) recognized in the syngeneic or allogeneic context predominantly linked to antigenic peptide loading to its binding groove.

P Nguyen van Binh1, H T Duc.   

Abstract

Class 1 major histocompatibility complex (MHC-I)-antigenic peptide exposed at the target cell surface is crucial for the adaptive immune response exerted in the self/syngeneic context by cytotoxic T lymphocyte (CTL). Such a complex also provides epitopes in the allogeneic context for antibody response directed against the MHC-I polymorphic determinant. In the present report we examined the formation of the MHC-I-peptide complex leading predominantly to the expression of T and/or B cell epitopes in a process of internal versus external antigenic peptide loading onto the binding groove of MHC-I. Analyses using antibodies specific to complex MHC-I-peptide generated in the syngeneic context to mimic T cell receptor (TCR) in comparison with antibodies specific to the MHC-I polymorphic determinant allowed the observation that the external peptide loading to MHC-I, while remaining necessary for inducing the formation of B cell epitopes, was less efficient than the internal one for generating T cell epitopes. Thus, external loading of peptide to the MHC-I appeared to match more closely the allogeneic situation and the humoral immunity in general, while internal peptide loading corresponded with the self/syngeneic context of the cellular CTL response.

Mesh:

Substances:

Year:  2006        PMID: 16879259      PMCID: PMC1809676          DOI: 10.1111/j.1365-2249.2006.03130.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Competitor analogs for defined T cell antigens: peptides incorporating a putative binding motif and polyproline or polyglycine spacers.

Authors:  J L Maryanski; A S Verdini; P C Weber; F R Salemme; G Corradin
Journal:  Cell       Date:  1990-01-12       Impact factor: 41.582

3.  Monoclonal antibodies directed against T cell epitopes presented by class I MHC antigens.

Authors:  H T Duc; P Rucay; S Righenzi; O Halle-Pannenko; P Kourilsky
Journal:  Int Immunol       Date:  1993-04       Impact factor: 4.823

Review 4.  Peptide binding to major histocompatibility complex molecules.

Authors:  L D Barber; P Parham
Journal:  Annu Rev Cell Biol       Date:  1993

5.  Assembly of MHC class I molecules analyzed in vitro.

Authors:  A Townsend; T Elliott; V Cerundolo; L Foster; B Barber; A Tse
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

Review 6.  Antigen processing and presentation by the class I major histocompatibility complex.

Authors:  I A York; K L Rock
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

7.  Introduction of soluble protein into the class I pathway of antigen processing and presentation.

Authors:  M W Moore; F R Carbone; M J Bevan
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

Review 8.  T-cell-mediated immunopathology in viral infections.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Transplant Rev       Date:  1974

Review 9.  The biochemistry and cell biology of antigen processing and presentation.

Authors:  R N Germain; D H Margulies
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

10.  Soluble T cell receptor-like properties of an HLA-B35-specific monoclonal antibody (TU165).

Authors:  B Uchańska-Ziegler; E Nössner; A Schenk; A Ziegler; D J Schendel
Journal:  Eur J Immunol       Date:  1993-03       Impact factor: 5.532

View more
  1 in total

1.  Design of a Multi-epitope Vaccine Against Acinetobacter baumannii Using Immunoinformatics Approach.

Authors:  Maryam Touhidinia; Fatemeh Sefid; Mozhgan Bidakhavidi
Journal:  Int J Pept Res Ther       Date:  2021-08-28       Impact factor: 1.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.